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ABSTRACT  
Background: There is considerable heterogeneity in long-term weight-loss among people 




sessions in the early weeks of the programme is an independent predictor of long-term 
success. 
Objective: To investigate whether frequency of attendance at a community weight-loss 
programme over the first 12 weeks is associated with long-term weight change.  
Methods: Participants were randomised to receive brief support only (control, n=211), or a 
weight-loss programme for 12-weeks (n=530) or 52-weeks (n=528). This study included 
participants with data on session attendance over the first 12 weeks (n=889), compared to 
the control group. The association between attendance (continuously) and weight loss was 
explored using a linear model. A multi-level mixed-effects linear model was used to 
investigate whether attendance (categorised as 0, 1, 2-5, 6-9 and 10-12 sessions) was 
associated with weight loss at 3, 12 and 24 months compared to the control.  
Results: For every session attended in the first 12 weeks, average weight loss was -
0.259kg/session at 24 months (P=0.005). Analysis by attendance group found only those 
attending 10-12 sessions had significantly greater weight loss (-7.5kg [95%CI -8.1 to -6.9] at 
12 months; -4.7kg [95%CI -5.3 to -4.1] at 24 months) compared to the control group (-3.4 
[95%CI -4.5 to -2.4] at 12 months, -2.5 [95%CI -3.5 to -1.5] at 24 months). Early attendance 
was higher for people ≥70 years, but there was no evidence of a difference by gender, 
ethnicity, education or income. 
Conclusions: Greater attendance at a community weight-loss programme in the first 12 
weeks is associated with enhanced weight-loss up to 24 months. Regular attendance at a 
programme could be used as a criterion for continued provision of weight-loss services to 









Behavioural weight management programmes are recommended for the treatment of 
overweight and obesity [1, 2].  There is good evidence that referral from a primary care 
practitioner to a community-based weight loss programme produces greater weight loss 
than self-guided efforts and that this is a cost-effective use of public finance [3-6]. However, 
there is significant inter-individual variation in outcome. Understanding the factors 
associated with long-term success may help to inform decisions about continued provision 
of weight loss support, facilitating more cost-effective treatments. 
Many studies have examined participant characteristics associated with weight loss, 
frequently identifying positive associations with older age, male gender, white ethnicity, 
higher body mass index (BMI) at baseline and higher levels of physical activity at baseline, 
but differences between groups are modest [7-11]. Greater overall attendance has also 
been reported to be associated with greater weight-loss [12, 8, 13-15, 11]. A recent study 
reported that attendance at one third of weekly meetings over 6 months was associated 
with 5-10% weight loss, and attendance at two thirds of weekly meetings was associated 
with ≥10% weight loss at 6 months. In a trial of an intervention comprising face-to-face and 
digital support, attendance at the group was more strongly associated with weight loss than 
use of the website or mobile app [11].  
There is also evidence that greater weight loss early in the programme predicts long-term 
weight loss [16, 17, 10, 18, 19], and it is likely that weight-loss and attendance are mutually 
reinforcing. However, it is not clear whether attendance to face to face sessions in the early 
weeks of the programme is an independent predictor of long-term success. If so, it may be a 




The Weight loss Referrals for Adults in Primary care (WRAP) trial showed that extending 
treatment duration from 12 to 52 weeks led to significantly greater weight loss at 24 
months [6]. However only 42% of participants randomised to receive treatment for 52 
weeks were continuing to attend the programme in the last 12 weeks of their referral [6]. 
Here we report an exploratory observational analysis of the WRAP trial to examine the 
association between attendance at a community-based weight loss programme over the 
first 12 weeks of an intervention study (“early attendance”) and weight change at 3, 12 and 
24 months. Our hypothesis was that higher attendance to the programme was associated 
with greater weight loss at 1 year. We also examined whether any effect is independent of 
weight loss achieved at 3 months. For comparison with previous studies, we also examine 
whether baseline characteristics predict attendance in the first 12 weeks of the programme. 
 
SUBJECTS, MATERIALS AND METHODS 
Study design 
The trial design, participants and interventions have been described previously [20]. In 
summary, WRAP was a multicentre, non-blinded, three-arm randomised controlled trial to 
examine weight loss after referral from a general practitioner to a commercial provider (CP; 
WW, formally Weight Watchers) [6]. Participants received brief support comprising written 
information to encourage self-help (control), or either 12-week or 52-week referrals to a 
community-based weight-loss programme.  
A final population of 1,269 eligible participants provided informed consent and were 




Participants referred to the CP were asked to attend a local WW meeting once a week for 
the duration of their treatment (12 weeks or 52 weeks). Participants were given either one 
voucher booklet for 12 weekly sessions (3 months), or 4 voucher booklets given quarterly 
(to be used once a week over 1 year). In addition, all CP participants were able to access 
WW digital tools (web and app-based) for the duration of their treatment. 
Participants were booked to attend trial measurement appointments at baseline, 3, 12, and 
24 months. Height was measured at baseline only with a stadiometer to the nearest 0·1 cm, 
weight was measured to the nearest 0·1 kg wearing light clothing and without shoes or 
socks (Tanita, Amsterdam, The Netherlands). Self-reported age, gender, ethnic group, 
education level, employment status and household income were also collected at baseline 
and follow up study visits. 
Attendance at the programme in the first 12 weeks 
Attendance in the first 12 weeks of the programme was recorded by the CP because the 
vouchers handed in were registered electronically.  Due to a computer system error, 
vouchers for a short time period were not recorded. For participants who were scheduled to 
attend during this period, attendance data from self-reported questionnaires was used and 
a sensitivity analysis conducted excluding self-reported data.  Where objective attendance 
data was missing we considered this to be missing at random as the only difference 
between those who had objective attendance data or not was the date when they were 
referred.  
Attendance at the CP was scheduled to be weekly and early attendance was recorded as a 




weeks) with available attendance data were categorised into one of 5 groups according to 
the number of sessions they attended in the first 12 weeks of their referral: 0 sessions, 
people who had no exposure whatsoever to the programme; 1, 2-5 and 6-9 sessions, which 
includes people who attended a variable number of sessions sporadically or continuously; or 
10-12 sessions, reflecting those who strongly engaged and attended most of the sessions 
(10-12). 
Sociodemographic characteristics 
Ethnicity was self-reported and grouped into White, Other and not stated. Education level 
data was grouped into: up to General Certificate of Secondary Education (GCSE, usually 
around 16y) or equivalent, A-level (around 18y) or equivalent, university degree or 
equivalent and higher degree or equivalent. Employment status was grouped into: “not 
employed” for those identifying as unemployed, student or unable to work, “employed” for 
those who were self-employed or employed by another, and “retired”. Household income 
data was divided into tertiles of <£20,000 per annum (p.a.), £20,000-39,999 p.a. and 
≥£40,000 p.a.  
Baseline observations were used for the following variables: age, employment, ethnicity, 
household income and level of education.  If baseline data were missing but present at 
subsequent visits 2 (3, 12 or 24-month follow up), this information was used with priority 
given to the earliest recorded measure. 
Statistical analysis  
All statistical analysis was conducted using STATA 14. Baseline characteristics were 




age; Kruskal-Wallis for BMI; chi-squared test for sex, intervention group, education level and 
household income; and a Fisher’s exact test for ethnic group and employment status. 
To investigate the association between weight loss and early attendance to the CP, we used 
a multivariable linear model treating attendance as a continuous exposure (0-12 sessions). 
For the main analysis, a multi-level mixed effects linear regression model with unstructured 
dependence variance-covariance structure was used treating attendance as a categorical 
exposure (0, 1, 2-5, 6-9 and 10-12 sessions). Each categorical attendance group was 
compared to the control group of the trial given these participants did not receive a referral 
to CP. To determine whether weight change for each attendance group was significantly 
different from the control group at each time point (3, 12 and 24 month visits), an 
interaction term (attendance group x visit) was included in the model. Potential 
confounders identified by the literature and available in the dataset were baseline age, sex, 
BMI, ethnicity, education level, employment status and household income. All were 
included in the models, in addition to the allocated intervention group (referral for 12 
weeks, 52 weeks or control) and attendance data source (CP-reported or self-reported). A 
separate model was conducted to analyse the association between early attendance and 
weight loss at 12 and 24 months while controlling for the amount of weight lost at 3 
months. In exploratory analyses we run those models within each of the intervention groups 
separately (12-week vs. 52-week referral). A sensitivity analysis was conducted to exclude 
those with only self-reported attendance data.  
The association between the baseline characteristics and early attendance was analysed 
using a multivariable linear regression model with attendance treated as a continuous 





The final sample analysed in this study (n=1,100) included participants with objectively 
recorded attendance data (n=632) or self-reported attendance data (n=257), as well as 
those in the control group (n=211) who were not referred to CP (Supplemental Appendix 1). 
We excluded n=169 participants who had missing information on attendance (objective 
and/or self-reported). Compared to the final study sample, those with missing attendance 
data were younger (49.9 years (SD 13.9) vs. 54.1 years (SD 13.5), P<0.001); more likely to 
have been referred for 12 weeks (61% vs. 48%, P<0.01) and less likely to be retired from 
work (19% vs. 32%, P<0.05). 
Table 1 shows the baseline characteristics of participants referred to CP with available 
attendance data. Of those with early attendance data (n=889), the mean age at baseline 
was 54.1 years (SD 13.5), the median BMI was 33.3 kg/m2 (IQR 30.6 to 37.1), 69% were 
female and 92% reported their ethnicity as White.  
Among those referred to a CP the median number of early sessions attended was 11 (IQR 6-
12) from a possible 12.  Of these, 76 (9%) participants did not attend any sessions in the first 
12 weeks, 36 (4%) participants only attended 1 session, 90 (10%) attended between 2 and 5 
sessions, 131 (15%) attended between 6 and 9 sessions, and 556 (63%) participants 
attended 10 or more sessions. This pattern of attendance in the first 12 weeks was not 
different between the intervention groups (Table 1; CP 12-week vs. 52-week, P=0.323), but 
the mean age (SD) was significantly different across the attendance groups (P<0.001). 
Although all participants had access to web and app-based tools, participants mostly 




53% and 49% or app-based support: 81%, 75%, 68%, 79% and 76% among participants 
attending 0, 1, 2-5, 6-9, 10-12 sessions respectively.  
Early attendance and weight change 
In the continuous analysis (Table 2), for every session attended in the first 12 weeks, 
average weight loss was -0.297 kg per session at 3 months (P<0.001), -0.404 kg per session 
at 12 months (P<0.001), and -0.259 kg per session at 24 months (P=0.005) in the fully 
adjusted model.  
Mean weight change in each attendance group at each time point is shown in Figure 1. Only 
participants who attended 10-12 sessions lost significantly more weight (-7.5 [95%CI -8.1 to 
-6.9] at 12 months; -4.7 [95%CI -5.3 to -4.1] at 24 months) compared to the control group (-
3.4 [95%CI -4.5 to -2.4] at 12 months, -2.5 [95%CI -3.5 to -1.5] at 24 months) (Table 3). We 
also investigated the association between each attendance group and weight loss at 12 and 
24 months after adjusting for the amount of weight lost at 3 months (Table 3). Participants 
attending 10-12 sessions lost significantly more weight than the control group at 12 months 
(-7.5 kg [95%CI -8.2 to -6.8] vs. -3.8 kg [95%CI -5.0 to -2.7], P<0.001) and 24 months (-4.7 kg 
[95%CI -5.4 to -4.0] vs. -3.1 kg [95%CI -4.3 to -1.9], P=0.034).  
Additional exploratory analyses investigated the associations within each of the active 
intervention groups separately (12-week referral and 52-week referral) and found results 
consistent with those presented in the main analysis described above. 
In a sensitivity analysis excluding those with only self-reported attendance data the 
conclusions from the main model as well as for the second model adjusted for weight loss at 




Baseline correlates of attendance 
In multivariable linear models, sex, BMI, education, income, employment, ethnicity and 
intervention group were not significantly associated with attendance (Table 4). Participants 
aged ≥70years old attended an average of 2.38 (95% CI 0.29-4.48) more sessions than the 
reference group aged <30 y. This difference was still significant at the 5% level after 
Bonferroni corrections to account for multiple testing. 
 
DISCUSSION 
Greater attendance to a community weight loss group in the first 12 weeks of the 
programme is associated with greater weight loss at 24 months. Weight loss among 
participants attending ≥10 of the first 12 sessions was greater than all other attendance 
groups at 12 and 24 months. The association between early attendance and long-term 
weight-loss is independent of the planned duration of the programme. The only significant 
socio-demographic predictor of greater attendance was age, with the older age group 
attending significantly more sessions than the younger age group. 
The main strength of this study is that it is based on a large randomised controlled trial with 
24-month follow up data. Including body weight for participants in the control group in the 
model allows us to isolate the effect of programme attendance from participation in a 
research study. This is important because evidence suggests that participation in a trial 
positively impacts on outcomes regardless of the intervention itself, leading to inflated 
estimates of the treatment effect in the absence of a control group [21].  Attendance at a 




data for 60% of participants, which provides confidence that the associations found are not 
caused by reporting bias. Unfortunately the study is limited by a computer system error 
which meant that attendance data was missing for 40% of participants and we had to rely 
on self-reported information on attendance. However, in a sensitivity analysis the exclusion 
of self-reported data did not change the observed associations. Another limitation was the 
small sample sizes in some of the attendance groups which limited the power of the 
exploratory and sensitivity analyses, although these were consistent with the main analysis. 
This analysis was also constrained by the data collected in the main randomised controlled 
trial and hence this observational analysis may still be affected by residual confounding 
related to factors such as prior history of weight loss or motivation to lose weight   
Early attendance at the programme was very high, with over 60% of participants attending 
10 or more sessions in the first 12 weeks (based on objectively recorded attendance data). 
This is similar to an independent analysis of 29,326 NHS referrals to the same programme 
which found that 54% of those referred attended all 12 sessions[22]. Another external audit 
of a different provider reported that approximately 58% of those referred attended ≥10 out 
of 12 sessions[23]. There was no difference in weight loss for groups of people attending for 
<10 weeks compared to the control group, however the relatively small proportion of 
people attending <10 sessions makes it difficult to establish whether there is a threshold 
level of attendance or a specific pattern of attendance (e.g. attending once or twice a month 
but regularly) which is associated with positive outcomes. The proportion of participants 
self-reporting use of web or app-based tools was low, particularly among those attending 




The finding that early weight loss is a strong predictor of long-term weight loss confirms 
previous findings [18, 19] and the positive association between attendance and weight loss is 
also consistent with the existing literature across a range of different behavioural weight loss 
programmes [24, 12, 9, 25]. However, additionally we have shown that early attendance 
predicted weight loss independent of the amount of weight lost over the first 12 weeks and 
independent of the length of treatment programme that participants were offered.    
Most of the sociodemographic characteristics measured in our study were not associated 
with attendance, except age. Other studies have also identified older age as being associated 
with higher attendance [26, 8, 27] and in some cases White ethnicity and education[28]. Other 
studies have shown that psychosocial factors, such as self-efficacy or being in the “action” 
stage of change, high perceived risk of cardiovascular disease, or a diagnosis of diabetes, are 
positively associated with greater overall attendance[29]. But the differences between groups 
are small. 
In routine practice it is not appropriate for practitioners to use sociodemographic factors as 
predictors of the likelihood of success in order to select people for referral to a weight-loss 
programme [17, 25, 30, 31]. Instead a more pragmatic approach would be to offer short-term 
interventions routinely to people who are overweight, which we have previously shown to be 
effective [5] and to base decisions on continued provision based on attendance at the 
programme. In the WRAP trial we observed that less than half of participants who received 
free vouchers to attend the programme for 1 year continued to do so over the last 12 weeks 
of the 1-year treatment [6], and providers could use regular attendance as a criterion for 
continued provision of services to improve the cost-effectiveness of these interventions.  




learning from prior research on communication practices to deliver health behaviour change 
[32].  
In conclusion, this study provides evidence that consistent attendance to a community-based 
weight loss programme during the first 12 weeks is significantly associated with greater 
weight loss at 24 months, independent of the magnitude of early weight loss. Regular 
attendance at a programme could be used as a criterion for continued provision of weight-
loss services to maximise the cost-effectiveness of interventions. 
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Table 1.  Summary of baseline characteristics by category of attendance among participants of the WRAP trial.  
  
Total 
 SESSIONS ATTENDED Between-group 









n (%)1 889 76 (8.6) 36 (4.1) 90 (10.1) 131 (14.7) 556 (62.5)  
Age - Mean (SD) 889 53.1 (12.9) 51.5 (11.4) 50.1 (14.8) 54.0 (12.0) 55.1 (13.7) F=5.11; P< 0.001 










χ2= 1.351; P=0.853 
























Intervention Group - n (%) 
Referral for 12 weeks of treatment 













































Education - n (%) 
≤ General Certificate of Secondary Education  



































































































1 Percentages total by row  




3 P values for differences between groups were determined using ANOVA for parametric data (age), Kruskal-Wallis test for non-parametric data (BMI) and Chi-





Table 2. Weight change at each time point for every extra session attended during the 
first 12 weeks among participants of the WRAP trial. 
 
  Change in weight (kg) [95% Confidence Interval] P value 
Unadjusted model1      
3 months -0.306 -0.369 to -0.242 <0.001 
12 months -0.499 -0.645 to -0.352 <0.001 
24 months -0.404 -0.557 to -0.251 <0.001 
Multivariable model2      
3 months -0.297 -0.365 to -0.230 <0.001 
12 months -0.404 -0.558 to -0.251 <0.001 
24 months -0.259 -0.422 to -0.097 0.002 
1 Unadjusted linear regression model 
2 Adjusted for baseline covariates: age, intervention group, BMI, employment status, ethnic group, 




Table 3. Weight change (kg) by category of attendance among participants of the WRAP trial. 
  
 
Mean weight change from baseline (kg)  
(95% confidence interval)1 
P values 
within attendance group 
comparing each visit to baseline2 
P values between 
attendance group 
comparing weight change 




in kg (SE) at 
baseline 
3 months 12 months 24 months 
Baseline 
to 3 m 
Baseline 
to 12 m 
Baseline 
to 24 m 
3 m 12 m 24 m 
Control  n=211 96.1 (1.1) -2.0 (-3.0 to -1.0) -3.4 (-4.5 to -2.4) -2.5 (-3.5 to -1.5) <0.001 <0.001 <0.001 - - - 
     4Adjusted for 3m WL   - - -3.8 (-5.0 to -2.7) -3.1 (-4.3 to -1.9) - <0.001 <0.001  - - 
0 Sessions n=76 97.8 (2.1) -3.1 (-4.6 to -1.7) -3.1 (-4.6 to -1.6) -1.6 (-3.1 to 0.0) <0.001 <0.001 0.047 0.193 0.724 0.317 
     4Adjusted for 3m WL   - - -2.6 (-4.3 to -1.0) -1.2 (-2.9 to 0.5) - 0.002 0.167  0.255 0.070 
1 Session n=36 93.9 (3.5) -3.5 (-6.2 to -0.9) -2.0 (-4.8 to 0.8) -0.1 (-2.9 to 2.6) 0.009 0.159 0.924 0.294 0.338 0.103 
     4Adjusted for 3m WL   - - -1.9 (-5.4 to 1.5) 0.2 (-3.4 to 3.8) - 0.271 0.912  0.302 0.083 
2-5 Sessions n=90 95.2 (1.5) -2.7 (-4.5 to -1.0) -4.8 (-6.7 to -2.8) -2.7 (-4.6 to -0.8) 0.002 <0.001 0.005 0.489 0.252 0.860 
     4Adjusted for 3m WL   - - -4.6 (-6.9 to -2.3) -2.7 (-5.0 to -0.4) - <0.001 0.019  0.573 0.763 
6-9 Sessions n=131 95.3 (1.6) -3.9 (-5.0 to -2.7) -3.8 (-5.1 to -2.6) -1.9 (-3.1 to -0.7) <0.001 <0.001 0.003 0.015 0.636 0.417 
     4Adjusted for 3m WL   - - -4.0 (-5.4 to -2.5) -2.2 (-3.6 to -0.8) - <0.001 0.002  0.876 0.340 
10-12 Sessions  n=556 96.0 (0.7) -5.8 (-6.4 to -5.2) -7.5 (-8.1 to -6.9) -4.7 (-5.3 to -4.1) <0.001 <0.001 <0.001 <0.001 <0.001 0.001 
     4Adjusted for 3m WL   - - -7.5 (-8.2 to -6.8) -4.7 (-5.4 to -4.0) - <0.001 <0.001  <0.001 0.034 
1 Results are mean change in weight from baseline at each follow up visit for each attendance group.  
2 P values within attendance group comparing weight loss between each time point and baseline, from multivariable multilevel mixed-effects linear regression models with categorical 
attendance groups adjusted for baseline covariates: age, intervention group, BMI, employment status, ethnic group, household income, sex and education. 
3 P values between attendance groups comparing weight change in each attendance group to the brief intervention group at each time point (interaction attendance group x visit), from 
multivariable multilevel mixed-effects linear regression models with categorical attendance groups adjusted for baseline covariates: age, intervention group, BMI, employment status, 




Table 4. Baseline predictors of early attendance to the programme among participants 







Sex      
Male -0.15 -0.83  0. 53 0.673 
Age group (y)      
30-39  -0.34 -2.06  1.38 0.701 
40-49  0.30 -1.30  1.90 0.712 
50-59  0.08 -1.53  1.68 0.925 
60-69 0.83 -0.92  2.58 0.353 
70+  2.42 0.37  4.47 0.021 
BMI (kg/m2)      
30-34.99 0.09 -0.81  1.00 0.837 
35-39.99 0.37 -0.63  1.37 0.471 
>40 0.58 -0.64  1.79 0.351 
Education       
A-Level, Post-Secondary study 0.52 -0.35  1.38 0.240 
University degree 0.53 -0.35  1.40 0.239 
Higher degree 0.24 -0.79  1.27 0.645 
Household income (pa)      
£20,000-39,999 0.01 -0.80  0.82 0.982 
£40,000+ 0.21 -0.70  1.13 0.647 
Ethnic group      
Other -0.44 -1.70  0.81 0.491 
Allocated intervention group      
Referral for 52 weeks of treatment 0.21 -0.42  0.84 0.510 
Employment      
Employed 0.74 -0.53  2.00 0.251 
Retired 0.30 -1.26  1.86 0.707 
Constant 7.09 5.01  9.16 <0.001 
Results are β (95% CI) from multivariable linear regression models, with the following reference 
groups: Female, <30 years old, BMI <30, White, Education level up to General Certificate of 















WRAP trial Flow Diagram 
 
Assessed for eligibility (n=1,954) 
Ineligible (n= 685) 
 
Allocated to control “Brief Intervention” 
(n=211) 
 Withdrew consent (n=37) 








Allocated to intervention “12 week CP” 
(n=530) 
 Withdrew consent (n=62); died (n=1) 
 Did not attend (n=60); ineligible (n=2) 
Allocated to intervention “52 week CP” 
(n=528) 
 Withdrew consent (n=29) 
 Did not attend (n=44) 
 
 Completed 3-m assessment (n=144) 
- Withdrew consent (n=15);  
- Did not attend (n=35) 
 Completed 12-m assessment (n=124) 
- Did not attend (n=26) 
 Completed 24-m assessment (n=133) 
 
 
Analysed (intention-to-treat; n= 211) 
• Objective attendance (n= 0) 
• Self-reported attendance (n= 0) 
• Missing attendance (n= 0) 
Analysed (intention-to-treat; n= 427) 
• Objective attendance (n= 272) 
• Self-reported attendance (n= 155) 
• Missing attendance (n= 103) 
Analysed (intention-to-treat; n= 462) 
• Objective attendance (n= 360) 
• Self-reported attendance (n= 102) 
• Missing attendance (n= 66) 
 Completed 3-m assessment (n=405) 
- Withdrew consent (n=29); died (n=1) 
- Did not attend (n=99) 
 Completed 12-m assessment (n=339) 
- Withdrew consent (n=6) 
- Did not attend (n=74) 
 Completed 24-m assessment (n=355) 
 
 
 Completed 3-m assessment (n=455) 
- Withdrew consent (n=33); died (n=3) 
- Did not attend (n=103) 
 Completed 12-m assessment (n=360) 
- Withdrew consent (n=12); died (n=1) 
- Did not attend (n=82) 
 Completed 24-m assessment (n=368) 
 
 
